Bruker Corp. (BRKR) stock forecast and price target
Price $61.59 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($61.59)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $2.13 | +16.3% | $3.5B |
| Next fiscal year ends December 31, 2027 | $2.43 | +14.1% | $3.7B |
| Next quarter ends December 31, 2026 | $0.77 | +31.2% | $1.0B |
| Quarter after ends March 31, 2027 | $0.43 | +39.3% | $856M |
Consensus of the analysts covering Bruker, updated daily. In the last 30 days 7 estimates were raised and 2 lowered.
Our model vs. Wall Street
Analysts see 10.4% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Bruker’s intrinsic value about 60% below today’s market value, and it scores 1.6 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Bruker stock price target?
The average 12-month target from 12 analysts is $68.00, 10.4% above the current price of $61.59 Targets range from $55.00 to $85.00.
Is Bruker a buy according to analysts?
The consensus rating is “Buy” (1 strong buy, 5 buy, 6 hold, 1 sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Bruker expected to earn?
Analysts expect EPS of $2.13 for the fiscal year ending December 31, 2026 and $2.43 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.